Rights and permissions
About this article
Cite this article
Extra cost of abciximab justified in PCI?. Inpharma Wkly. 1288, 6 (2001). https://doi.org/10.2165/00128413-200112880-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112880-00011